Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.
- DOI
- 10.1038/s41408-025-01263-3
- Published
- 2025 Mar 28
- Container
- Blood cancer journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-025-01263-3,
title = {Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.},
author = {Pullarkat V and Pratz KW and Döhner H and Recher C and Thirman MJ and DiNardo CD and Fenaux P and Schuh AC and Wei AH and Pigneux A and Jang JH and Juliusson G and Miyazaki Y and Selleslag D and Arellano ML and Liu C and Ridgeway JA and Potluri J and Schuler J and Konopleva M},
year = {2025},
journal = {Blood cancer journal},
doi = {10.1038/s41408-025-01263-3},
url = {https://doi.org/10.1038/s41408-025-01263-3}
}RIS
TY - JOUR TI - Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia. AU - Pullarkat V AU - Pratz KW AU - Döhner H AU - Recher C AU - Thirman MJ AU - DiNardo CD AU - Fenaux P AU - Schuh AC AU - Wei AH AU - Pigneux A AU - Jang JH AU - Juliusson G AU - Miyazaki Y AU - Selleslag D AU - Arellano ML AU - Liu C AU - Ridgeway JA AU - Potluri J AU - Schuler J AU - Konopleva M PY - 2025 JO - Blood cancer journal DO - 10.1038/s41408-025-01263-3 UR - https://doi.org/10.1038/s41408-025-01263-3 ER -
APA
V, P., KW, P., H, D., C, R., MJ, T., CD, D., P, F., AC, S., AH, W., A, P., JH, J., G, J., Y, M., D, S., ML, A., C, L., JA, R., J, P., J, S., & M, K. (2025). Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.. Blood cancer journal. https://doi.org/10.1038/s41408-025-01263-3
Source records
- pubmed · retrieved 2026-09-27T10:28:55.813Z